Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease

Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease

**Background:** The mainstay first-line therapy for chronic graft-vs-host disease (cGVHD) is corticosteroids; however, for steroid-refractory patients, there is a distinct lack of cost-effective or efficacious treatment. The aim of this study was to assess the cost-effectiveness of extracorporeal ph...

Full description

Saved in:
Bibliographic Details
Main Authors: Adrian Peacock, Frances C. Dehle, Oscar A. Mesa Zapata, Francesca Gennari, Maro R.I. Williams, Nada Hamad, Stephen Larsen, Simon J. Harrison, Colman Taylor
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2024-02-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.92028
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items